GILD - Gilead Sciences Inc.

GILD valuation $158.15 billion

Stock Price

104.83
Change: ↑ 0.65 (0.62392%)
Last Update: 2015-01-30T16:15:58-05:00
Shares Outstanding: 1,508,664,333
Industry: Biotechnology
Website Investor Relations

Gilead Sciences, Inc., or simply known as Gilead, is a research centered biotechnology firm that discovers, produces and commercializes medicines. The company was founded in 1987 as Oligogen, Inc. by DuBose Montgomery. Gilead’s primary field of work is on immunodeficiency virus (HIV), liver diseases like hepatitis, B and C, and respiratory and cardiovascular complications. The company operates in Europe, North America, and Asia. Gilead’s products include Truvada, Viread, Atripla, Tamiflu, Complera, Vistide, Renexa, Letairis, Emtrica, Raspiscan and Hepsera. As of 2010, the company had more than 4,000 employees.

Gilead Sciences has experienced rapid growth over the years because of their diversity and acquisitions. They acquired Nexstar Pharmaceuticals for $550 million in 1999, Triangle Pharmaceuticals for $464 million in 2003; Corus Pharma, Inc. in 2006; Myogen, Inc. in 2006; Raylo Chemicals, Inc. in 2006; Nycomed fr. Altana – Cork, a commercial manufacturing site in 2007; CV Therapeutics, Inc. in 2009; CGI Pharmaceuticals in 2010; Arresto Biosciences, Inc. in 2010; Calistoga Pharmaceuticals in 2011, Pharmasset, Inc. in 2011 and YM Biosciences, Inc. in 2013. Gilead has been experiencing high revenue earnings over the past few years. This is mainly due to the fact that the medical industry remains unaffected to economic situations. In 2011, revenue earning for Gilead were $8.39 Billion, followed by incredible $9.7 Billion revenue in 2012. The half yearly revenue of $5.3 Billion shows the company will likely increase its revenue from last year’s. Analysts have calculated annual revenue of $10.8 Billion in 2013 and a staggering $13.4 Billion in 2014. 

Stock Price Data

Open: 104.33 Previous Close: 104.18
High: 106.27 Low: 103.73
Bid: 105.05 Ask: 105.17

Bid Size: 100 Ask Size: 100
Raw Bid Size: 1 Raw Ask Size: 1
Trade Volume: 84813 Share Volume: 13182250
Last Trade Date: 2015-01-30 Last Trade Time: 16:15:00-05:00
Vwap: 105.0318975 EPS: 5.64

Fundamental Data

PE ratio: 18.50 PB ratio: 11.661
Beta: 0.768151

52 Week High: 116.83 52 Week Low: 63.50
52 Week High Vwap: 113.5606 52 Week Low Vwap: 66.8991
52 Week High Volume: 72464172 52 Week Low Volume: 6591005
52 Week Avg Volume: 15036043
* Quotes delayed 15 minutes

Related Stocks

StockCompany namePrice
IMGN ImmunoGen Inc. 7.63
CELG Celgene Corporation 119.16
ARNA Arena Pharmaceuticals Inc. 4.31
MNKD MannKind Corporation 6.35
AMGN Amgen Inc 152.26
NVAX Novavax Inc. 7.81
BIIB Biogen Idec Inc. 389.16
NPSP NPS Pharmaceuticals Inc. 45.86
ARIA ARIAD Pharmaceuticals Inc. 6.45
PDLI PDL BioPharma Inc. 7.29